Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20709233 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes
Condition: Cardiovascular Disease
Interventions: Drug: Rimonabant;   Drug: Placebo (for Rimonabant)

Study has passed its completion date and status has not been verified in more than two years.